Zhejiang Medicine Co., Ltd. (SHA:600216)

Zhejiang Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,636	1,460	1,438	1,769	1,629	1,278
Short-Term Investments	-	-	-	2.9	50	151.35
Trading Asset Securities	328.2	328.31	447.29	454.4	270.73	328.63
Cash & Short-Term Investments	1,964	1,788	1,885	2,226	1,950	1,758
Cash Growth	14.45%	-5.15%	-15.30%	14.17%	10.91%	0.12%
Accounts Receivable	1,905	1,419	1,501	1,594	1,402	1,606
Other Receivables	134.88	239.14	67.35	105.17	141.38	94.05
Receivables	2,040	1,658	1,568	1,699	1,544	1,700
Inventory	1,945	2,011	1,995	1,873	1,480	1,435
Prepaid Expenses	-	-	0.03	0.36	0.9	3
Other Current Assets	197.51	143.88	207.17	236.04	143.85	143.77
Total Current Assets	6,147	5,601	5,655	6,035	5,118	5,039
Property, Plant & Equipment	6,183	6,019	5,618	5,360	4,513	4,459
Long-Term Investments	150.59	166.21	144.51	126.07	195.48	209.13
Goodwill	18.68	18.68	27.91	36.03	-	-
Other Intangible Assets	698.67	744.3	747.68	728.81	409.75	406.89
Long-Term Deferred Tax Assets	84.48	82.12	77.41	78.8	86.49	77.39
Long-Term Deferred Charges	12.44	6.22	8.85	0.41	27.18	28.26
Other Long-Term Assets	134.9	141.15	153.27	167.76	150.18	142.39
Total Assets	13,430	12,780	12,433	12,532	10,500	10,362
Accounts Payable	1,173	744.03	702.48	897.83	504.75	637.39
Accrued Expenses	137.63	253.95	263.98	287.32	534.42	433.24
Short-Term Debt	235.23	231.41	82.25	225.33	250.31	649.98
Current Portion of Long-Term Debt	141.66	370.37	550.64	-	200.17	-
Current Portion of Leases	-	0.3	0.28	-	-	-
Current Income Taxes Payable	211.93	11.88	21.75	153.51	95.69	46.41
Current Unearned Revenue	45.69	43.95	61.88	53.81	54.6	51.52
Other Current Liabilities	412.54	822.53	782.11	1,407	284.22	232.03
Total Current Liabilities	2,358	2,478	2,465	3,025	1,924	2,051
Long-Term Debt	372.31	230.22	200.19	250.34	500.65	-
Long-Term Leases	0.53	0.32	0.62	1.16	-	-
Long-Term Unearned Revenue	89.12	84.16	54.11	53.08	34.24	36.56
Long-Term Deferred Tax Liabilities	-	-	2.47	21.12	11.38	23.02
Total Liabilities	2,820	2,793	2,723	3,350	2,470	2,110
Common Stock	961.64	964.98	965.13	965.13	965.13	965.13
Additional Paid-In Capital	1,988	2,005	1,941	1,692	1,398	1,343
Retained Earnings	7,388	6,682	6,417	6,195	5,371	5,611
Treasury Stock	-	-27.63	-57.69	-59.98	-59.98	-59.98
Comprehensive Income & Other	4.38	5.77	-5.27	-13.99	0.41	1.4
Total Common Equity	10,341	9,631	9,260	8,779	7,675	7,861
Minority Interest	268.1	355.68	449.98	402.93	355.48	391.39
Shareholders' Equity	10,609	9,986	9,710	9,182	8,030	8,252
Total Liabilities & Equity	13,430	12,780	12,433	12,532	10,500	10,362
Total Debt	749.73	832.63	833.97	476.82	951.12	649.98
Net Cash (Debt)	1,214	955.7	1,051	1,749	998.53	1,108
Net Cash Growth	32.77%	-9.10%	-39.89%	75.16%	-9.87%	-12.12%
Net Cash Per Share	1.27	0.99	1.09	1.82	1.04	1.16
Filing Date Shares Outstanding	961.64	925.92	958.3	958.3	958.3	958.3
Total Common Shares Outstanding	961.64	925.92	958.3	958.3	958.3	958.3
Working Capital	3,789	3,123	3,190	3,010	3,194	2,989
Book Value Per Share	10.75	10.40	9.66	9.16	8.01	8.20
Tangible Book Value	9,624	8,868	8,484	8,014	7,265	7,454
Tangible Book Value Per Share	10.01	9.58	8.85	8.36	7.58	7.78
Buildings	-	2,919	2,812	2,509	2,171	2,031
Machinery	-	6,897	6,158	5,366	4,839	4,692
Construction In Progress	-	931.69	825.71	1,119	638.83	466.84

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.